Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.
Fuchs M, Jacob AS, Kaul H, Kobe C, Kuhnert G, Pabst T, Greil R, Bröckelmann PJ, Topp MS, Just M, Hertenstein B, Soekler M, Vogelhuber M, Zijlstra JM, Keller UB, Krause SW, Dührsen U, Meissner J, Viardot A, Eich HT, Baues C, Diehl V, Rosenwald A, Buehnen I, von Tresckow B, Dietlein M, Borchmann P, Engert A, Eichenauer DA. Fuchs M, et al. Among authors: dietlein m. Leukemia. 2024 Jan;38(1):160-167. doi: 10.1038/s41375-023-02064-y. Epub 2023 Oct 16. Leukemia. 2024. PMID: 37845285 Free PMC article. Clinical Trial.
Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
van Heek L, Weindler J, Gorniak C, Kaul H, Müller H, Mettler J, Baues C, Fuchs M, Borchmann P, Ferdinandus J, Dietlein M, Voltin CA, Kobe C, Roth KS. van Heek L, et al. Among authors: dietlein m. Eur J Haematol. 2023 Dec;111(6):881-887. doi: 10.1111/ejh.14093. Epub 2023 Aug 29. Eur J Haematol. 2023. PMID: 37644732
Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.
Ferdinandus J, van Heek L, Roth K, Dietlein M, Eich HT, Baues C, Borchmann P, Kobe C. Ferdinandus J, et al. Among authors: dietlein m. Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):490-495. doi: 10.1007/s00259-023-06431-w. Epub 2023 Sep 22. Eur J Nucl Med Mol Imaging. 2024. PMID: 37735258 Free PMC article. Clinical Trial.
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy.
Voltin CA, Gödel P, Beckmann L, Heger JM, Kobe C, Kutsch N, Borchmann P, Dietlein M, Herrmann K, Stelljes M, Rahbar K, Lenz G, Reinhardt HC, Teichert M, Noppeney R, Albring JC, Seifert R, von Tresckow B, Flossdorf S, Hanoun C. Voltin CA, et al. Among authors: dietlein m. Hemasphere. 2023 Jan 6;7(1):e817. doi: 10.1097/HS9.0000000000000817. eCollection 2023 Jan. Hemasphere. 2023. PMID: 36698613 Free PMC article.
Case report: Use of 68Ga-DOTATATE-PET for treatment guidance in complex meningioma disease.
Meißner AK, von Spreckelsen N, Al Shughri A, Brunn A, Fuertjes G, Schlamann M, Schmidt M, Dietlein M, Rueß D, Ruge MI, Galldiks N, Goldbrunner R. Meißner AK, et al. Among authors: dietlein m. Front Oncol. 2022 Oct 12;12:1017339. doi: 10.3389/fonc.2022.1017339. eCollection 2022. Front Oncol. 2022. PMID: 36313670 Free PMC article.
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group.
Rosenbrock J, Kaul H, Oertel M, Celik E, Linde P, Fan J, Eichenauer DA, Bröckelmann PJ, von Tresckow B, Kobe C, Dietlein M, Fuchs M, Borchmann P, Eich HT, Baues C. Rosenbrock J, et al. Among authors: dietlein m. Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00514-5. doi: 10.1016/j.ijrobp.2024.04.015. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38631539 Free article.
PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor Volume.
Knaup H, Weindler J, van Heek L, Voltin CA, Fuchs M, Borchmann P, Dietlein M, Kobe C, Roth K. Knaup H, et al. Among authors: dietlein m. Acad Radiol. 2023 Dec 27:S1076-6332(23)00691-8. doi: 10.1016/j.acra.2023.12.016. Online ahead of print. Acad Radiol. 2023. PMID: 38155023 Free article.
272 results